DB16151InvestigationalProtein Based Therapies
Efungumab is under investigation in clinical trial NCT00217815 (Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer).
- Also known as
- Hsp-90mab · Hsp90mab · Immunoglobulin, anti-(candida heat-shock protein hsp 90) (human monoclonal hsp90mab fragment) · Mycograb
- Code names
- MYC-123 · MYC-123A · MYC-123B · MYC-124
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Efungumab, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account